116 related articles for article (PubMed ID: 9820082)
1. [Steroid osteoporosis].
Kocián J
Vnitr Lek; 1998 Feb; 44(2):86-92. PubMed ID: 9820082
[TBL] [Abstract][Full Text] [Related]
2. Anabolic steroids in corticosteroid-induced osteoporosis.
Adami S; Rossini M
Wien Med Wochenschr; 1993; 143(14-15):395-7. PubMed ID: 8256456
[TBL] [Abstract][Full Text] [Related]
3. [Disorders of bone mineralization and their treatment in Crohn's disease].
Kocián J; Kociánová J
Vnitr Lek; 1998 Mar; 44(3):162-5. PubMed ID: 9820096
[TBL] [Abstract][Full Text] [Related]
4. Effect of long-term calcitonin administration on steroid-induced osteoporosis after cardiac transplantation.
Kapetanakis EI; Antonopoulos AS; Antoniou TA; Theodoraki KA; Zarkalis DA; Sfirakis PD; Chilidou DA; Alivizatos PA
J Heart Lung Transplant; 2005 May; 24(5):526-32. PubMed ID: 15896748
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of patients with postmenopausal osteoporosis and steroid-induced osteoporosis with the preparation Rocaltrol (1,25/OH/2 vitamin D3)].
Koev D; Todorova S; Diankov L; Khristova D; Tsachev K
Vutr Boles; 1988; 27(2):117-22. PubMed ID: 3414094
[TBL] [Abstract][Full Text] [Related]
6. [Post-steroidal osteoporosis].
Drozdzowska B; Pluskiewicz W
Przegl Lek; 1999; 56(2):157-60. PubMed ID: 10375951
[TBL] [Abstract][Full Text] [Related]
7. [Prevalence of steroid osteoporosis].
Mori S
Clin Calcium; 2006 Nov; 16(11):1782-7. PubMed ID: 17079843
[TBL] [Abstract][Full Text] [Related]
8. [New data on the pathogenesis of steroid-induced osteoporosis: consequences for therapy and prevention].
Hüfner M; Siggelkow H
Dtsch Med Wochenschr; 2003 Jul; 128(30):1602-8. PubMed ID: 12884149
[No Abstract] [Full Text] [Related]
9. [Glucocorticoid-induced osteoporosis].
Tóth M; Tulassay Z
Orv Hetil; 2000 Jan; 141(5):219-23. PubMed ID: 10697979
[TBL] [Abstract][Full Text] [Related]
10. Effect of calcitriol on bone mineral density in premenopausal Chinese women taking chronic steroid therapy. A randomized, double blind, placebo controlled study.
Lambrinoudaki I; Chan DT; Lau CS; Wong RW; Yeung SS; Kung AW
J Rheumatol; 2000 Jul; 27(7):1759-65. PubMed ID: 10914864
[TBL] [Abstract][Full Text] [Related]
11. [Pathogenesis of corticoid-induced osteoporosis].
Ringe JD
Fortschr Med; 1990 Jul; 108(20):393-6. PubMed ID: 2202618
[TBL] [Abstract][Full Text] [Related]
12. Teriparatide (biosynthetic human parathyroid hormone 1-34): a new paradigm in the treatment of osteoporosis.
Brixen KT; Christensen PM; Ejersted C; Langdahl BL
Basic Clin Pharmacol Toxicol; 2004 Jun; 94(6):260-70. PubMed ID: 15228497
[TBL] [Abstract][Full Text] [Related]
13. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
14. Prevention of corticosteroid induced osteoporosis in inpatients recently discharged from a tertiary teaching hospital.
Smith MD; Cheah SP; Taylor K; Ahern MJ
J Rheumatol; 2001 Mar; 28(3):566-70. PubMed ID: 11296960
[TBL] [Abstract][Full Text] [Related]
15. Management of bone loss in inflammatory bowel disease.
Lichtenstein GR
Semin Gastrointest Dis; 2001 Oct; 12(4):275-83. PubMed ID: 11726081
[TBL] [Abstract][Full Text] [Related]
16. [Corticosteroid-induced osteoporosis].
Trombetti A; Pennisi P; Rizzoli R
Rev Prat; 2004 Dec; 54(19):2132-7. PubMed ID: 15724591
[TBL] [Abstract][Full Text] [Related]
17. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].
Brodowska A
Ann Acad Med Stetin; 2003; 49():111-30. PubMed ID: 15552843
[TBL] [Abstract][Full Text] [Related]
18. [Pathological bone density in chronic inflammatory bowel diseases--prevalence and risk factors].
Von Tirpitz C; Pischulti G; Klaus J; Rieber A; Brückel J; Böhm BO; Adler G; Reinshagen M
Z Gastroenterol; 1999 Jan; 37(1):5-12. PubMed ID: 10091278
[TBL] [Abstract][Full Text] [Related]
19. [Risk of osteoporosis in steroid therapy. When and how to counter the risk].
Kirchgatterer A; Aschl G; Hinterreiter M; Knoflach P
MMW Fortschr Med; 2001 Jun; 143(25):37-9. PubMed ID: 11468995
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacological prevention of osteoporosis in patients on corticosteroid medication].
Lems WF; Jacobs JW; Netelenbos JC; Dijkmans BA; Bijlsma JW
Ned Tijdschr Geneeskd; 1998 Aug; 142(34):1904-8. PubMed ID: 9856175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
